Latest News

Rivaroxaban gets FDA approval for treatment in CAD or PAD

Rivaroxaban, brand name Xarelto (Janssen), has received approval by the US Food and Drug Administration (FDA) to reduce the risk of major cardiovascular (CV)...


Expanding patient care options with Medtronic

This article is an advertorial by Medtronic. In collaboration with leading clinicians, researchers and scientists worldwide, Medtronic Inc. offers the broadest range of innovative medical...

The dialysis access landscape in 2018: Challenges, advances and future directions

Guidelines of the European Society for Vascular Surgery1 give an overview of the current best evidence for vascular access for dialysis. Although these guidelines...


 “The instructions for use (IFU) are not a clinical guideline, so trainees should really think about what the main considerations are when they are implanting devices in the aorta to create a durable repair,” said Tara Mastracci (Royal Free...


Alison Halliday

Tilo Kölbel

Michael Edmonds

(Visited 48,034 times, 1 visits today)